Clinical Trial Update: Non-invasive Ways to Evaluate Lung Disease After Treatment With Xolair [Phase 4]

View source ↗

Summary

Phase 4 trial update describing non-invasive methods to evaluate lung disease after treatment with Xolair (omalizumab); the study is reported as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Xolair (omalizumab)

Snippet

Sponsor: Creighton University | Conditions: Lung Disease | Phase 4 | Status: COMPLETED